Unit of Psychiatry, Department of Neuroscience, Uppsala University, Uppsala, Sweden.
Centre for Pharmacoepidemiology at the Department of Medicine, Karolinska Institutet, Solna, Sweden.
J Intern Med. 2015 Jun;277(6):727-36. doi: 10.1111/joim.12329. Epub 2014 Dec 8.
The aim of this study was to explore the impact of severe mental illness (SMI) on myocardial infarction survival and determine the influence of risk factor burden, myocardial infarction severity and different treatments.
DESIGN, SETTING AND PARTICIPANTS: This population-based cohort study, conducted in Sweden during the period 1997-2010, included all patients with a first diagnosis of myocardial infarction in the Swedish nationwide myocardial infarction register SWEDEHEART (n = 209 592). Exposure was defined as a diagnosis of SMI (i.e. bipolar disorder or schizophrenia) in the national patient register prior to infarction. Bias-minimized logistic regression models were identified using directed acyclic graphs and included covariates age, gender, smoking, diabetes, previous cardiovascular disease, myocardial infarction characteristics and treatment.
The outcomes were 30-day and 1-year mortality, obtained through linkage with national population registers.
Patients with bipolar disorder (n = 442) and schizophrenia (n = 541) were younger (mean age 68 and 63 years, respectively) than those without SMI (n = 208 609; mean age 71 years). The overall 30-day and 1-year mortality rates were 10% and 18%, respectively. Compared with patients without SMI, patients with SMI had higher 30-day [odds ratio (OR) 1.99, 95% confidence interval (CI) 1.55-2.56] and 1-year mortality (OR 2.11, 95% CI 1.74-2.56) in the fully adjusted model. The highest mortality was observed amongst patients with schizophrenia (30-day mortality: OR 2.58, 95% CI 1.88-3.54; 1-year mortality: OR 2.55, 95% CI 1.98-3.29).
SMI is associated with a markedly higher mortality after myocardial infarction, also after accounting for contributing factors. It is imperative to identify the reasons for this higher mortality.
本研究旨在探讨严重精神疾病(SMI)对心肌梗死患者生存的影响,并确定危险因素负担、心肌梗死严重程度和不同治疗方法的影响。
设计、地点和参与者:这项基于人群的队列研究于 1997 年至 2010 年在瑞典进行,纳入了瑞典全国性心肌梗死登记处 SWEDEHEART 中所有首次诊断为心肌梗死的患者(n=209592)。暴露定义为在梗死前国家患者登记册中诊断为 SMI(即双相情感障碍或精神分裂症)。使用有向无环图确定了偏最小二乘逻辑回归模型,并包括年龄、性别、吸烟、糖尿病、既往心血管疾病、心肌梗死特征和治疗等协变量。
通过与全国人口登记处的链接,获得 30 天和 1 年死亡率。
与没有 SMI 的患者(n=208609;平均年龄 71 岁)相比,患有双相情感障碍(n=442)和精神分裂症(n=541)的患者年龄更小(平均年龄分别为 68 岁和 63 岁)。总体 30 天和 1 年死亡率分别为 10%和 18%。与没有 SMI 的患者相比,在完全调整后的模型中,SMI 患者的 30 天(比值比[OR]1.99,95%置信区间[CI]1.55-2.56)和 1 年死亡率(OR 2.11,95% CI 1.74-2.56)更高。在精神分裂症患者中观察到最高的死亡率(30 天死亡率:OR 2.58,95% CI 1.88-3.54;1 年死亡率:OR 2.55,95% CI 1.98-3.29)。
在考虑到相关因素后,SMI 与心肌梗死后死亡率明显升高相关。确定这种更高死亡率的原因至关重要。